Cardiovascular magnetic resonance imaging in suspected cardiac tumour: a multicentre outcomes study
Authors' conclusion
In patients with suspected cardiac tumour, CMR has high diagnostic accuracy. Patients with CMR diagnoses of no mass, pseudomass, and benign tumour have similar long-term mortality. The CMR diagnosis is a powerful independent predictor of mortality incremental to clinical risk factors.
Study context
- Population
- Patients undergoing clinical cardiovascular magnetic resonance (CMR) for suspected cardiac tumour376 died
- Participants
- 903 patients
- Comparison
- CMR diagnosis categories
- Outcome
- All-cause mortality
- Follow-up
- Median 4.9 years
Main finding
As reported in the abstract
All-cause mortality by CMR diagnosis
No mass
25%
Share of patients
Pseudomass
16%
Share of patients
Thrombus
16%
Share of patients
Benign tumour
17%
Share of patients
Malignant tumour
23%
Share of patients
Each group vs no massHazard ratio (CI)
Malignant tumour
3.31(2.40–4.57)
Thrombus
1.46(1.00–2.11)
Further findings
Diagnostic accuracy of CMR vs final diagnosis
- CMR diagnosis accurate
- 98.4%
Incremental prognostic value of CMR diagnosis over clinical factors (LVEF, CAD, history of extracardiac malignancy)
- CMR diagnosis added incremental prognostic value
- P < 0.001
Original publication
Cardiovascular magnetic resonance imaging in suspected cardiac tumour: a multicentre outcomes study. Eur Heart J. Published 21 September 2021. doi:10.
Summarised from the published abstract; every number is checked against it